Active substance
Glipizide
- SFDA 4
- US FDA 24
- US price lines 6
- NHS prices 1
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| GLIPOM 5MG TABLETS | 5 mg | Tablet · Oral use | 20 Blister | SAR 5.40 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| SUCRAZIDE 5MG TAB | 5 mg | Tablet · Oral use | 30 Blister | SAR 7.60 | Generic · Prescription | DAR ALDAWA | Valid |
| GLIBENESE TABLETS 5 MG. | 5 mg | Tablet · Oral use | 30 Blister | SAR 19.65 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
| MINIDIAB 5 mg tablet | 5 mg | Tablet · Oral use | 30 Blister | SAR 9.60 | Generic · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
DIABETES MELLITUS TYPE 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| GLUCOTROL XL | 5MG; 10MG | tablet, extended release · oral | PFIZER | Prescription | 26 Apr 1994 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | AUROBINDO PHARMA USA | Prescription | 10 May 1994 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | OXFORD PHARMS | Prescription | 28 Nov 1994 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | WATSON LABS TEVA | Prescription | 27 Feb 1995 |
| GLIPIZIDE | 5MG; 10MG; 2.5MG | tablet · oral | AIPING PHARM INC | Prescription | 7 Apr 1995 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | ANI PHARMS | Prescription | 31 Aug 1995 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | APOTEX | Prescription | 13 Jun 2001 |
| GLIPIZIDE | 5MG; 10MG; 2.5MG | tablet, extended release · oral | WATSON LABS | Prescription | 8 Sep 2003 |
| GLIPIZIDE | 2.5MG; 5MG; 10MG | tablet, extended release · oral | UNIQUE | Prescription | 29 Dec 2016 |
| GLIPIZIDE | 2.5MG; 5MG; 10MG | tablet, extended release · oral | AUROBINDO PHARMA | Prescription | 12 May 2017 |
| GLIPIZIDE | 2.5MG; 5MG; 10MG | tablet, extended release · oral | ZYDUS PHARMS | Prescription | 16 Jul 2018 |
| GLIPIZIDE | 2.5MG; 5MG; 10MG; 15MG | tablet · oral | RUBICON RESEARCH | Prescription | 3 Oct 2023 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | GRAVITI PHARMS | Prescription | 4 Mar 2026 |
| GLUCOTROL | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | PFIZER | Discontinued | 8 May 1984 |
| GLUCOTROL XL | 2.5MG | tablet, extended release · oral | PFIZER | Discontinued | 26 Apr 1994 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | WATSON LABS | Discontinued | 22 Nov 1994 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | PHARMOBEDIENT | Discontinued | 20 Jun 1995 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | CHARTWELL RX | Discontinued | 20 Jun 1995 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | ANI PHARMS | Discontinued | 4 Mar 1996 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | BARR LABS INC | Discontinued | 4 Apr 1997 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | ACCORD HLTHCARE | Discontinued | 11 Sep 1997 |
| GLIPIZIDE | 5MG; 10MG | tablet · oral | SUN PHARM INDS INC | Discontinued | 11 Jul 2006 |
| GLIPIZIDE | 10MG; 5MG | tablet, extended release · oral | PH HEALTH | Discontinued | 20 Sep 2013 |
| GLIPIZIDE | 2.5MG; 5MG; 10MG | tablet, extended release · oral | PHARMOBEDIENT | Discontinued | 19 May 2015 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | GLIPIZIDE 10 MG TABLET | $0.04476 | per EA | 23 Sep 2026 |
| US NADAC | GLIPIZIDE 2.5 MG TABLET | $1.26741 | per EA | 23 Sep 2026 |
| US NADAC | GLIPIZIDE 5 MG TABLET | $0.03388 | per EA | 23 Sep 2026 |
| US NADAC | GLIPIZIDE ER 10 MG TABLET | $0.12172 | per EA | 23 Sep 2026 |
| US NADAC | GLIPIZIDE ER 2.5 MG TABLET | $0.09927 | per EA | 23 Sep 2026 |
| US NADAC | GLIPIZIDE ER 5 MG TABLET | $0.07375 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Glipizide 5mg tablets | £1.26 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 10 Aug 2018 GLUCOTROL XL — safety-related labeling change
Labeling sections changed: Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide - US FDA 18 Aug 2016 GLUCOTROL — safety-related labeling change
Labeling sections changed: Drug Interactions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.